[1] Anglim PP,Alonzo TA,Laird-offringa IA. DNA Methylation-based biomarkers for early detection of non-small cell lung cancer:an update[J]. MolCancer,2008,7(1):81. [2] 周际昌.实用肿瘤内科学[M].北京.人民卫生出版社,2000:34. [3] 张天泽,徐光炜.肿瘤学[M].天津:天津科学技术,2005:2791. [4] Geridelli C,Langer C,Mauibe P,et al. Lung cancer in the elderly[J]. J Clin Oncol,2007,25(14):1898-1907. [5] Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics[J]. CA Cancer J clip,2005,(55):74-108. [6] Montazeri A,Mikoy R,Hole D,et al. Quality of life in lung cancer patients as a important prognostic factor[J]. Lung Cancer,2001,3(2-3):223-240. [7] Kiely BE,Alam-M,Blinman p,et al. Estimating typical,best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer:A systematic review of contemporary randomized trials[J]. Lung Cancer,2012,77(3),537-544. [8] Wao H,Mhaskar R,Kumar A,et al. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis[J]. Syst Rev,2013,(2),2-10. [9] de Marinis F,Pereira JR,Fossella F,et al. Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures:an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer[J]. J Thorac Oncol,2008,3(1):30-36. [10] 胡凯文,郑洪霞,齐静,等.浙贝母碱逆转白血病细胞多药耐药的研究[J]. 中华血液学杂志,1999,(12):33-34.
[1]王利芬.中药联合甲氨蝶呤治疗输卵管妊娠142例[J].环球中医药,2013,6(04):284.
[2]王淙悦 喻明 王华伟等.中药应用于肿瘤转移的20年用药规律探索[J].环球中医药,2014,7(02):113.
[3]崔娣 胡晓冬 夏清青.中药联合化疗治疗晚期非小细胞肺癌疗效及对患者生存期的影响[J].环球中医药,2014,7(03):219.
[4]秦兰.宫颈癌术后同步放化疗辅以中药内服的临床观察及毒副反应分析[J].环球中医药,2013,6(06):424.
QIN Lan..Clinical effect and toxicity reaction of radiotherapy and chemotherapy combined with Chinese medicine in treating cervical cancer[J].,2013,6(01):424.
[5]徐和,戴领,沈成英,等.基于MTT法的波棱瓜子抗肝纤维化用量初步研究[J].环球中医药,2013,6(08):589.
XU He,DAI Ling,SHEN Cheng ying,et al.Research on the administration dosage for antihepatic fibrosis of Herpetospermum caudigerum based on MTT assay[J].,2013,6(01):589.
[6]刘永衡,郎娜,陈秀,等.中药复方逆转肿瘤多药耐药研究近况及相关PI3K/AKT/NF_(-κ)B分子通路分析[J].环球中医药,2013,6(09):704.
LIU Yong heng,LANG Na,CHEN Xiu..Traditional Chinese medicine compound in reversal of multidrug resistance in tumors and the analysis on PI3K/AKT/NFκB molecular pathway[J].,2013,6(01):704.
[7]王雪冰,张伟,李淼,等.中药外治干预化疗相关消化道反应的疗效观察[J].环球中医药,2013,6(11):858.
[8]李炯辉,刘莹.中药治疗肿瘤放射治疗后损伤的临床研究进展[J].环球中医药,2012,5(11):869.
LI Jiong hui,LIU Ying..Clinical research progress of TCM in treating injury after radiotherapy of tumor[J].,2012,5(01):869.
[9]王秀霞,梁玲,薛会灵,等.近5年中药治疗原发性痛经临床研究进展[J].环球中医药,2012,5(02):157.
WANG Xiu-xia,LIANG Ling,XUE Hui-ling,et al.Study progression on treatment of primary dysmenorrhea by Chinese herbs in recent five years[J].,2012,5(01):157.
[10]吴海建 高瑞岭 张俊清等.中西医结合治疗女阴湿疹60例[J].环球中医药,2014,7(07):542.